Savara (SVRA) Non-cash Items (2013 - 2026)

Savara (SVRA) reported Non-cash Items of $11.6 million for Q1 2026, down 28.83% year-over-year from $16.3 million in Q1 2025, and up 38.69% on a QoQ basis from $8.4 million in Q4 2025.

Savara (SVRA) has 14 years of Non-cash Items data on file, last reported at $11.6 million in Q1 2026.

  • Quarterly Non-cash Items fell 28.83% year-over-year to $11.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.6 million (down 28.83% YoY) and the FY2025 annual result came in at $8.4 million, down 27.81% from the prior year.
  • Non-cash Items improved to $11.6 million in Q1 2026 per SVRA's latest filing, from $8.4 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $25.4 million in Q4 2023 and bottomed at $1.2 million in Q1 2022.
  • The 5-year median for Non-cash Items is $7.2 million (2024), against an average of $7.8 million.
  • The widest annual swing landed in 2023, when Non-cash Items jumped 1663.33%; it then tumbled 54.37% in 2024.
  • Tracing SVRA's Non-cash Items over 5 years: stood at $1.4 million in 2022, then jumped by 1663.33% to $25.4 million in 2023, then plunged by 54.37% to $11.6 million in 2024, then declined by 27.81% to $8.4 million in 2025, then jumped by 38.69% to $11.6 million in 2026.
  • Per Business Quant, the three latest SVRA Non-cash Items figures stand at $11.6 million (Q1 2026), $8.4 million (Q4 2025), and $5.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Savara 1.30 Bn 1.30 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 11.60 Mn
Mar 31, 2026 11.60 Mn
Dec 31, 2025 8.36 Mn
Dec 31, 2025 8.36 Mn
Sep 30, 2025 5.30 Mn
Sep 30, 2025 5.30 Mn
Jun 30, 2025 15.40 Mn
Jun 30, 2025 15.40 Mn
Mar 31, 2025 16.30 Mn
Mar 31, 2025 16.30 Mn
Dec 31, 2024 11.59 Mn
Dec 31, 2024 11.59 Mn
Sep 30, 2024 7.20 Mn
Sep 30, 2024 7.20 Mn
Jun 30, 2024 7.60 Mn
Jun 30, 2024 7.60 Mn
Mar 31, 2024 8.30 Mn
Mar 31, 2024 8.30 Mn
Dec 31, 2023 25.39 Mn
Dec 31, 2023 25.39 Mn
Sep 30, 2023 4.70 Mn
Sep 30, 2023 4.70 Mn
Jun 30, 2023 1.80 Mn
Jun 30, 2023 1.80 Mn
Mar 31, 2023 2.00 Mn
Mar 31, 2023 2.00 Mn
Dec 31, 2022 1.44 Mn
Dec 31, 2022 1.44 Mn
Sep 30, 2022 2.30 Mn
Sep 30, 2022 2.30 Mn
Jun 30, 2022 2.70 Mn
Jun 30, 2022 2.70 Mn
Mar 31, 2022 1.20 Mn
Mar 31, 2022 1.20 Mn
Dec 31, 2021 354,000.00
Dec 31, 2021 354,000.00
Dec 31, 2020 190,000.00
Dec 31, 2020 190,000.00
Dec 31, 2019 461,000.00
Dec 31, 2019 461,000.00
Dec 31, 2018 7.98 Mn
Dec 31, 2018 7.98 Mn
Dec 31, 2017 22.50 Mn
Dec 31, 2017 22.50 Mn
Mar 31, 2017 2.10 Mn
Mar 31, 2017 2.10 Mn
Dec 31, 2016 13.87 Mn
Dec 31, 2016 13.87 Mn
Sep 30, 2016 4.80 Mn
Sep 30, 2016 4.80 Mn
Jun 30, 2016 5.30 Mn
Jun 30, 2016 5.30 Mn
Mar 31, 2016 5.90 Mn
Mar 31, 2016 5.90 Mn
Dec 31, 2015 10.43 Mn
Dec 31, 2015 10.43 Mn
Sep 30, 2015 4.80 Mn
Sep 30, 2015 4.80 Mn
Jun 30, 2015 5.20 Mn
Jun 30, 2015 5.20 Mn
Mar 31, 2015 4.40 Mn
Mar 31, 2015 4.40 Mn
Dec 31, 2014 374,000.00
Dec 31, 2014 374,000.00
Sep 30, 2014 4.00 Mn
Sep 30, 2014 4.00 Mn
Jun 30, 2014 5.30 Mn
Jun 30, 2014 5.30 Mn
Mar 31, 2014 3.10 Mn
Mar 31, 2014 3.10 Mn
Dec 31, 2013 2.60 Mn
Dec 31, 2013 2.60 Mn